• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK, INC. ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK, INC. ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TFFB-22-82-ZT
Device Problem Other (for use when an appropriate device code cannot be identified) (2203)
Patient Problem Unspecified Infection (1930)
Event Date 03/10/2014
Event Type  Injury  
Event Description
A study indicated that a (b)(6) female patient underwent evar for aaa on (b)(6) 2014.Maximum aortic aneurysm diameter was listed as 20.8 mm and inner diameter of the aorta just above the aortic bifurcation was 6.0 mm, and of the right iliac was 7.4 mm.The proximal neck was parallel in shape with no plaque or thrombus.There was no difficulty deploying any of the devices (one zenith flex main body and two zenith iliac leg grafts with spiral-z technology).A molding balloon was used during the study procedure.Uncovered stents were placed in both iliac legs at the time of the procedure due to occlusion (1820334-2014-00159).The completion angiogram showed that the devices were patent, with no evidence of external compression, kinks, thrombus, or endoleaks.On (b)(6) 2014 (21 days post-procedure), the patient was admitted to the hospital due to a wound infection from the evar procedure.The patient had been placed on cipro 1 week earlier but the wound was "looking worse".After admission, the patient was to receive levaquin and flagyl.During the initial infusion of levaquin, the patient began having respiratory distress and became hypotensive.The infusion was stopped, the patient was given 100 mg of hydrocortisone, and placed on a nonrebreather o2 mask.She then developed rapidly progressive bilateral lower extremity pains and pulses could not be palpated.A stat ultrasound showed occlusion of the right lower extremity arterial system extending from at least the common femoral artery down.The left side could not be imaged.The patient was taken urgently to the operating room for a bilateral iliofemoral thromboembolectomy with left femoral endarterectomy with patch angioplasty.The right iliofemoral endarterectomy was closed with primary repair.Hematology consultation on (b)(6) 2014 (22 days post-procedure) indicated "thrombosis of the aortic and iliac graft (1820334-2014-00159).This was probably triggered by a combination of recent surgery and hypotension.She probably also has peripheral vascular disease from her smoking, hypertension, and hyperlipidemia." multiple lab tests were to be checked in order to rule out any intrinsic hypercoagulable state - none of those results are available.District manager spoke to physician (b)(6) 2014 providing the following additional information: the physician said that he did not believe this had anything to do with the graft.The physician said he thought the patient developed a clot in the lower extremity that worked its way upward because they lost pulses in the lower extremities.The physician also said he thought it was related to the antibiotics given and that the patient had some sort of allergic reaction that triggered their blood to clot.The physician told the district manager that he felt the graft was patent and there were no limb kinks because after he and the other physician had performed the bilateral iliofemoral thromboembolectomy, bilateral distal pulses were restored.The physician did not feel an angiogram was needed at the time to look at the graft.As of (b)(6) 2014 patient is recovering.
 
Manufacturer Narrative
(b)(4).Event evaluation: still under investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
COOK, INC.
bloomington IN 47404
Manufacturer Contact
rita harden, director
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key3980824
MDR Text Key4822813
Report Number1820334-2014-00307
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Type of Report Initial
Report Date 03/11/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/17/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2015
Device Catalogue NumberTFFB-22-82-ZT
Device Lot Number4501828
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/10/2014
Device Age6 MO
Event Location Hospital
Date Manufacturer Received06/24/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/18/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-